Milan, Italy

Mauro Galantino

This inventor holds 1 USPTO granted patent. Top assignee: Farmitalia Carlo Erba. Active years: 1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mauro Galantino. Retrieved from https://idiyas.com/inventor/mauro-galantino

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1992

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mauro Galantino: Innovator in Peptide Ligands

Introduction

Mauro Galantino is a notable inventor based in Milan, Italy. He has made significant contributions to the field of biochemistry, particularly in the development of peptide ligands. His work focuses on advancing medical science through innovative solutions.

Latest Patents

Mauro Galantino holds a patent for "Irreversible peptide ligands for bombesin receptors, their use, and a peptide of formula (I)." This patent represents a crucial advancement in the understanding and application of peptide ligands in medical treatments.

Career Highlights

Galantino is currently employed at Farmitalia Carlo Erba, where he continues to push the boundaries of research and development in pharmaceuticals. His expertise in peptide chemistry has positioned him as a key figure in his organization.

Collaborations

Mauro collaborates with talented colleagues, including Marina Ciomei and Isabella Molinari. Together, they work on various projects that aim to enhance the efficacy of peptide-based therapies.

Conclusion

Mauro Galantino's innovative work in peptide ligands exemplifies the impact of dedicated research in the pharmaceutical industry. His contributions are paving the way for future advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…